Status:
COMPLETED
SARS-CoV-2 Seroprevalence Among Nursing Home Staff and Residents (COVID-19)
Lead Sponsor:
Sciensano
Collaborating Sponsors:
KU Leuven
University of Liege
Conditions:
Covid19
SARS-CoV-2 Infection
Eligibility:
All Genders
18+ years
Brief Summary
Assessment of the seroprevalence and sero-incidence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) among Nursing Home (NH) residents and staff in Belgium.
Detailed Description
In this longitudinal cohort study, 3036, nursing home (NH) residents (1656) and staff (1380), spread over 69 nursing homes throughout Belgium will be repeatedly sampled at a 2-month interval. Seroprev...
Eligibility Criteria
Inclusion
- residents and staff from Belgian nursing homes
Exclusion
- service flat residents
- temporary staff, employed for a period of less then 1 year starting from baseline collection
Key Trial Info
Start Date :
February 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2022
Estimated Enrollment :
3008 Patients enrolled
Trial Details
Trial ID
NCT04738695
Start Date
February 1 2021
End Date
December 31 2022
Last Update
November 24 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ghent University
Ghent, Oost-Vlaanderen, Belgium, 9000